News & Events about Ani Pharmaceuticals Inc.
Equities research analysts forecast that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP Get Rating) will post earnings of $0.04 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for ANI Pharmaceuticals earnings, with the highest...
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows: H.C. Wainwright Global Investment Conference (Virtual) Date: Tuesday, May 24...
Thrivent Financial for Lutherans decreased its position in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP Get Rating) by 3.5% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 7,834 shares of the specialty pharmaceutical companys stock after ...